Acurx Pharmaceuticals, Inc. (ACXP) — Institutional Holders, Q2 2026
20 institutional investment managers reported a ACXP position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $192.8K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
ACXP in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- Integrated Wealth ConceptsNew · +4,729 sh+$7.3K
- Tower Research Capital (TRC)Added · +1,713 sh+$2.7K
- GEODE CAPITAL MANAGEMENTAdded · +1,592 sh+$2.5K
- MORGAN STANLEYAdded · +1,000 sh+$1.6K
- Caitong International Asset Management , LtdNew · +23 sh+$36.00
Biggest sellers
- JANE STREET GROUPTrimmed · -38,915 sh-$60.3K
- Cambridge Investment Research AdvisorsSold out · -20,000 sh-$31.0K
- UBS Group AGTrimmed · -6,309 sh-$9.8K
- Western Wealth ManagementSold out · -1,325 sh-$2.1K
- MCGUIRE CAPITAL ADVISORSSold out · -1,000 sh-$1.6K
ACXP 13F holders ranked 1–20 of 20
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT#1 · 31,099 sh | 31,099 | $48.2K | 0.00% | 0.0% |
| 2 | GEODE CAPITAL MANAGEMENT#2 · 26,411 sh | 26,411 | $40.9K | 0.00% | +6.4% |
| 3 | VANGUARD FIDUCIARY#3 · 16,205 sh | 16,205 | $25.1K | 0.00% | 0.0% |
| 4 | JANE STREET GROUP#4 · 15,727 sh | 15,727 | $24.4K | 0.00% | -71.2% |
| 5 | Prospect Financial Services#5 · 13,785 sh | 13,785 | $21.4K | 0.01% | 0.0% |
| 6 | MORGAN STANLEY#6 · 7,500 sh | 7,500 | $11.6K | 0.00% | +15.4% |
| 7 | Integrated Wealth Concepts#7 · 4,729 sh | 4,729 | $7.3K | 0.00% | New |
| 8 | Tower Research Capital (TRC)#8 · 2,744 sh | 2,744 | $4.3K | <0.01% | +166.1% |
| 9 | WELLS FARGO & COMPANY#9 · 2,300 sh | 2,300 | $3.6K | 0.00% | 0.0% |
| 10 | Westside Investment Management#10 · 1,650 sh | 1,650 | $2.6K | <0.01% | 0.0% |
| 11 | NBC SECURITIES#11 · 1,500 sh | 1,500 | $2.3K | — | 0.0% |
| 12 | BARCLAYS PLC#12 · 281 sh | 281 | $436.00 | 0.00% | -26.1% |
| 13 | Cornerstone Planning Group#13 · 167 sh | 167 | $245.00 | — | 0.0% |
| 14 | OSAIC#14 · 100 sh | 100 | $155.00 | 0.00% | 0.0% |
| 15 | GROUP ONE TRADING, L.P.#15 · 95 sh | 95 | $147.00 | 0.00% | -61.2% |
| 16 | BlackRock#16 · 60 sh | 60 | $93.00 | 0.00% | 0.0% |
| 17 | Caitong International Asset Management , Ltd#17 · 23 sh | 23 | $36.00 | 0.00% | New |
| 18 | SBI Securities , Ltd.#18 · 6 sh | 6 | $9.00 | — | 0.0% |
| 19 | UBS Group AG#19 · 3 sh | 3 | $5.00 | 0.00% | -100.0% |
| 20 | NewEdge Advisors#20 · 0 sh | 0 | $0.00 | 0.00% | New |
Funds that sold out of ACXP in Q2 2026 (5)
Held ACXP at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Cambridge Investment Research Advisors20,000 sh | 20,000 | $74.0K |
| Western Wealth Management1,325 sh | 1,325 | $4.9K |
| MCGUIRE CAPITAL ADVISORS1,000 sh | 1,000 | $3.7K |
| Advisory Services Network59 sh | 59 | $219.00 |
| CITIGROUP1 sh | 1 | $4.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.